FLMNY: AI 评分 48/100 — AI 分析 (4月 2026)

Fielmann AG is a German-based optical and hearing aid business operating across Europe. The company manufactures and sells visual and hearing aids through its extensive network of retail stores and online platforms.

Key Facts: AI Score: 48/100 Sector: Healthcare

公司概况

概要：

Fielmann AG is a leading European optical and hearing aid provider, distinguished by its vertically integrated business model, encompassing manufacturing, retail, and online sales. With a strong presence in Germany and expanding operations across Europe, Fielmann offers a wide range of eyewear and hearing solutions, catering to diverse customer needs.

FLMNY是做什么的？

Founded in 1972 and headquartered in Hamburg, Germany, Fielmann Aktiengesellschaft has grown to become a prominent player in the European optical and hearing aid market. The company operates through a network of 693 stores as of December 31, 2021, with a significant presence in Germany (610 stores), Switzerland (45), Austria (38), Italy (43), Poland (37), and Spain (87), along with smaller operations in Luxembourg, Slovenia, and other Eastern European countries. Fielmann manufactures and sells a comprehensive range of visual aids, including glasses, frames, lenses, sunglasses, contact lenses, and accessories. Additionally, the company offers hearing aids and related accessories. Fielmann's business model integrates manufacturing, retail distribution, and online sales channels. Fielmann Aktiengesellschaft is a subsidiary of Korva SE.

FLMNY的投资论点是什么？

Fielmann AG presents a notable market position based on its established market position, vertically integrated business model, and expansion strategy. The company's strong brand recognition and extensive retail network provide a solid foundation for growth. With a P/E ratio of 19.57 and a profit margin of 7.5%, Fielmann demonstrates financial stability. A dividend yield of 2.70% offers income potential for investors. Key catalysts include continued expansion in Southern and Eastern Europe, and increased online sales. Potential risks include increased competition and fluctuations in currency exchange rates. The company's beta of 0.65 suggests lower volatility compared to the overall market.

FLMNY在哪个行业运营？

The medical instruments and supplies industry is characterized by innovation, regulatory oversight, and evolving consumer preferences. The aging population and increasing awareness of eye and hearing health are driving demand for optical and hearing aid products. Fielmann AG competes with other major players in the European market, including those focused on low-cost solutions and those offering premium brands. The industry is also experiencing a shift towards online sales and telemedicine, requiring companies to adapt their business models.

Medical - Instruments & Supplies

Healthcare

FLMNY有哪些增长机遇？

Expansion in Southern and Eastern Europe: Fielmann has the opportunity to further expand its presence in Southern and Eastern European markets, where demand for affordable and high-quality optical and hearing solutions is growing. This expansion could involve opening new stores, acquiring existing businesses, or establishing partnerships with local retailers. This offers potential to capture a larger share of the European market, estimated to reach $45 billion by 2028.
Increased Online Sales: Fielmann can leverage its online platform to drive sales growth and reach a wider customer base. By investing in e-commerce capabilities, digital marketing, and online customer service, the company can capitalize on the increasing trend of online shopping for eyewear and hearing aids. The global e-commerce market for eyewear is projected to reach $22 billion by 2027.
Product Innovation: Fielmann can invest in research and development to introduce new and innovative products that cater to evolving customer needs and preferences. This could include developing advanced lens technologies, smart glasses, or personalized hearing solutions. The global market for smart glasses is expected to reach $15 billion by 2028.
Partnerships with Healthcare Providers: Fielmann can forge strategic partnerships with healthcare providers, such as ophthalmologists and audiologists, to offer integrated eye and hearing care solutions. This could involve establishing co-located clinics, offering referral programs, or developing joint marketing campaigns. This can drive customer acquisition and enhance brand reputation.
Focus on Sustainability: Fielmann can enhance its brand image and attract environmentally conscious customers by adopting sustainable business practices. This could include using eco-friendly materials, reducing waste, and promoting ethical sourcing. The global market for sustainable eyewear is growing, driven by increasing consumer awareness of environmental issues.

Market capitalization of $4.17 billion, reflecting its significant presence in the European optical market.
Gross margin of 80.2%, indicating efficient cost management and strong pricing power.
Operates 693 stores across Europe as of December 31, 2021, providing extensive retail coverage.
Dividend yield of 2.70%, offering a steady income stream for investors.
Employs 20,221 people, showcasing its operational scale and market reach.

FLMNY提供哪些产品和服务？

Manufactures and sells glasses, frames, and lenses.
Offers sunglasses and contact lenses.
Provides hearing aids and accessories.
Operates a network of retail stores across Europe.
Sells products through online stores.
Invests in and operates optical and hearing aid businesses.

FLMNY如何赚钱？

Vertically integrated model encompassing manufacturing, retail, and online sales.
Focus on providing affordable and high-quality optical and hearing solutions.
Extensive network of retail stores in key European markets.

Individuals seeking vision correction.
Individuals with hearing impairments.
Fashion-conscious consumers looking for stylish eyewear.
Customers seeking affordable optical and hearing solutions.

Strong brand recognition in the European market.
Extensive retail network providing convenient access for customers.
Vertically integrated business model enabling cost control and quality assurance.
Long-standing relationships with suppliers and partners.

什么因素可能推动FLMNY股价上涨？

Ongoing: Expansion into new European markets, driving revenue growth.
Ongoing: Increased online sales through enhanced e-commerce platform.
Upcoming: Potential partnerships with healthcare providers to offer integrated services.
Ongoing: Product innovation and development of advanced lens technologies.

FLMNY的主要风险是什么？

Potential: Increased competition from existing players and new entrants.
Potential: Fluctuations in currency exchange rates impacting profitability.
Potential: Economic downturns affecting consumer spending on discretionary items.
Ongoing: Regulatory changes in the healthcare industry.
Potential: Supply chain disruptions affecting product availability.

FLMNY的核心优势是什么？

Strong brand recognition in Europe
Extensive retail network
Vertically integrated business model
High gross margin

FLMNY的劣势是什么？

Limited presence outside of Europe
Dependence on retail sales
Exposure to currency fluctuations
Competition from online retailers

FLMNY有哪些机遇？

Expansion into new geographic markets
Growth in online sales
Development of innovative products
Partnerships with healthcare providers

FLMNY面临哪些威胁？

Increased competition
Changing consumer preferences
Economic downturns
Regulatory changes

FLMNY的竞争对手是谁？

EssilorLuxottica SA — Global leader in eyewear and lens manufacturing. — (ADDLF)
Amplifon SpA — Leading hearing care retailer. — (AHICF)
Asahi Glass Co Ltd — Manufactures glass for lenses. — (AKBLF)
Carl Zeiss Meditec AG — Develops medical technology for ophthalmology. — (CLCGY)
CooperCompanies — Manufactures and markets contact lenses. — (CSMYF)

Key Metrics

MoonshotScore: 48/100

Company Profile

CEO: Marc Fielmann
Headquarters: Hamburg, DE
Employees: 20,221
Founded: 2017

AI Insight

AI analysis pending for FLMNY

ADR Level: 1
ADR Ratio: 1:1
Home Market Ticker: FLMN

OTC Tier: OTC Other
Disclosure Status: Unknown

常见问题

What does Fielmann AG do?

Fielmann AG is a leading European optical and hearing aid provider. The company manufactures and sells a wide range of eyewear products, including glasses, frames, lenses, and sunglasses, as well as contact lenses and accessories. Additionally, Fielmann offers hearing aids and related accessories. The company operates through a network of retail stores across Europe and also sells its products through online channels. Fielmann's business model focuses on providing affordable and high-quality optical and hearing solutions to a broad customer base.

What do analysts say about FLMNY stock?

Analyst coverage of FLMNY may be limited due to its OTC listing and ADR status. However, based on available financial data, Fielmann AG demonstrates a solid financial profile with a gross margin of 80.2% and a profit margin of 7.5%. The company's P/E ratio of 19.57 suggests a reasonable valuation. Growth considerations include expansion into new markets, increased online sales, and product innovation. Investors should conduct their own due diligence and consider the risks associated with investing in OTC stocks.

What are the main risks for FLMNY?

The main risks for FLMNY include increased competition in the European optical and hearing aid market, fluctuations in currency exchange rates, and potential economic downturns affecting consumer spending. As an OTC-listed stock, FLMNY also carries risks associated with limited financial disclosure, low trading volume, and potential price volatility. Investors should carefully consider these risks before investing in FLMNY.